Pediatrix GC Dominic Andreano to step down; Mary Ann Moore appointed successor

Pediatrix Medical Group, Inc.

Andreano to depart as EVP, General Counsel and Secretary effective Oct. 14, 2022.
Termination is without cause; he will receive benefits after signing release.
He intends to enter into a consulting agreement to advise the company post-transition.
Mary Ann Moore, EVP, Chief Enterprise Risk & Legal Operations, will succeed as GC.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Mary Ann Moore

Executive Vice President, General Counsel and Secretary

MD · Pediatrix Medical Group, Inc.

Effective: 2022-10-14
Filed: September 23, 2022, 7:59 PM ET

Ms. Mary Ann Moore, the Company’s Executive Vice President, Chief Enterprise Risk and Legal Operations Officer, will be appointed the Company’s Executive Vice President, General Counsel and Secretary upon Mr. Andreano’s transition from his current role.

Departed

Dominic J. Andreano

Executive Vice President, General Counsel and Secretary

MD · Pediatrix Medical Group, Inc.

Effective: 2022-10-14
Successor: Mary Ann Moore
Filed: September 23, 2022, 7:59 PM ET

On September 19, 2022, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), announced that Dominic J. Andreano, the Company’s Executive Vice President, General Counsel and Secretary, would transition from such position, effective on or about October 14, 2022 (the “Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mary Ann Moore was appointed as Executive Vice President, General Counsel and Secretary at Pediatrix Medical Group, Inc..

Action: appointed
Role: Executive Vice President, General Counsel and Secretary

Exact text from the filing

Ms. Mary Ann Moore, the Company’s Executive Vice President, Chief Enterprise Risk and Legal Operations Officer, will be appointed the Company’s Executive Vice President, General Counsel and Secretary upon Mr. Andreano’s transition from his current role.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Dominic J. Andreano changed role as Executive Vice President, General Counsel and Secretary at Pediatrix Medical Group, Inc..

Action: transition
Role: Executive Vice President, General Counsel and Secretary

Exact text from the filing

On September 19, 2022, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), announced that Dominic J. Andreano, the Company’s Executive Vice President, General Counsel and Secretary, would transition from such position, effective on or about October 14, 2022 (the “Effective Date”).

View on SEC.gov

Pediatrix Medical Group, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-250187

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.